As we mark a decade of our John Goldman Fellowship Awards, we caught up with one of our very first Fellows - Dr Elspeth (Beth) Payne, clinician and researcher. 🎥 Beth reflects on how the Fellowship helped shape her career in academic medicine…

Researchers have used gene-editing tools to map mutations in the ABL1 kinase domain - a critical component driving CML - and identify which of these mutations are resistant to certain drugs, opening the door to more personalised treatment options. 👏 https://t.co/ZahctQSerF

Thank you @CliveJonesMP for leading today's Westminster Hall debate and raising the issues faced by leukaemia patients. Our thanks also to @DrScottArthurMP for echoing our call to ensure the upcoming 10-Year Workforce Plan enables and supports the National Cancer Plan.

Exciting news! Researchers have now uncovered why proteasome inhibitors, a class of drugs that work well in multiple myeloma, aren’t as effective in AML patients - and how to change this. 👏 Read more: https://t.co/ArOaqZq5t5

Thank you @GavinWilliamson for raising Ruth’s case in Parliament and asking @DHSCgovuk what steps are being taken to support patients with AML. We welcome @AshleyDalton_MP's recommitment to improving AML survival, something we are calling for in the upcoming National Cancer Plan.

We’re thrilled to have co-supported Molecular Haemopoiesis 2025, bringing together leading researchers exploring blood cell development. 🩸 It was great to see some of our past & present John Goldman Fellows deliver fascinating talks, and see such impactful science in action! 🔬

We’re delighted to announce our second John Goldman Fellow for 2025 and this year’s Olive Boles Innovation Award winner - Dr @horne_gillian from @UofGlasgow! 🔬 Her research focuses on building better diagnostic tools to treat Ph+ ALL. Read more: https://t.co/62veeOGfqs

⚠️ Last chance to make your voice heard and tell the Government to stop avoidable delays in leukaemia diagnosis. Join us in demanding better for leukaemia patients ➡️ https://t.co/A44IWCiJRW #CountUsIn

Humble to receive the John Goldman Fellowship from Leukaemia UK to support our work to find gentler and more targeted therapies for acute lymphoblastic leukaemia. @EdinUniMedicine

📢 We’re funding two new groundbreaking studies, each aimed at developing kinder, more effective treatments for acute lymphoblastic leukaemia (ALL). Meet Dr @StefanoComazze1 from the Uni of Edinburgh - one of our two new John Goldman Fellows for 2025. https://t.co/uAvkEtZ0IZ

Unfortunately, Tracey’s story isn’t uncommon. A shocking 1 in 4 leukaemia patients experience avoidable delays in their diagnosis. It’s time to change this. 💪 Join us in calling for the Government to commit to taking action ➡️ https://t.co/A44IWCiJRW #CountUsIn

This month, we’re celebrating a very special milestone: 10 years of our John Goldman Fellowship funding programme. ✨ Over the past decade, our Fellowships have empowered early-career researchers to pursue ideas that push the boundaries of science. 🔗: https://t.co/Hu20o4RhYL

You can still help to ensure change happens, by writing to the Government and highlighting our findings ➡️  https://t.co/A44IWCjhHu #LabourPartyConference (2/2)

A fantastic few days at the #Lab25 conference, speaking with MPs and policymakers, including @wesstreeting, about our #CountUsIn campaign and the need for the upcoming National Cancer Plan to stop avoidable delays in leukaemia diagnosis. (1/2)

Strong conversation with @YasinForBedford at #Lab25 about the challenges in diagnosing leukaemia earlier. Thank you for engaging with us and showing support for the change people affected by leukaemia need.

Thank you @Peter_Dowd for visiting us at #Lab25 and for supporting our call for the National Cancer Plan to address the delays in diagnosing leukaemia. Together we can stop leukaemia devastating lives.

We were glad to welcome @JonAshworth to our stand at Labour Conference. Early diagnosis is key and we’re calling for it to be embedded in the National Cancer Plan.

Thank you to @Cllr_Alisa for visiting our stand to discuss how we can work together to improve early diagnosis, treatment and care of leukaemia within the Afro-Caribbean community

A big thank you to @JNJInnovMedUK for supporting our project to improve early diagnosis of leukaemia. It was a pleasure to welcome @RichardGthatsme to our stand. Thank you for all you do to support better outcomes for people with blood cancer.

Thanks @tobyperkinsmp for taking time at #Lab25 to meet us. We discussed the importance of ensuring that earlier leukaemia diagnosis is prioritised across the NHS.